Literature DB >> 29086412

Research gaps in the management and prevention of cutaneous squamous cell carcinoma in organ transplant recipients.

M Blomberg1,2, S Y He3, C Harwood4, S T Arron5, S Demehri1, A Green6,7, M M Asgari1,2.   

Abstract

Although tremendous progress has been made in recent years in skin cancer care for organ transplant recipients, significant gaps remain in data-driven clinical guidelines, particularly for the treatment and prevention of cutaneous squamous cell carcinoma (cSCC), the most common malignancy among this population. In this review, we aim to summarize current knowledge around the management of cSCC and highlight the most significant gaps in knowledge that continue to pose challenges in the delivery of skin cancer care for organ transplant recipients. We suggest future directions for research that will bridge existing gaps and establish evidence-driven guidelines for primary prevention, screening and treatment of cSCC in this high-risk patient population.
© 2017 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29086412      PMCID: PMC5711582          DOI: 10.1111/bjd.15950

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  68 in total

Review 1.  Intralesional 5-fluorouracil (FU) as a treatment for nonmelanoma skin cancer (NMSC): A review.

Authors:  Lauren Metterle; Christopher Nelson; Nishit Patel
Journal:  J Am Acad Dermatol       Date:  2015-11-11       Impact factor: 11.527

2.  The occurrence of residual or recurrent squamous cell carcinomas in organ transplant recipients after curettage and electrodesiccation.

Authors:  Y G L de Graaf; V R Basdew; N van Zwan-Kralt; R Willemze; J N Bouwes Bavinck
Journal:  Br J Dermatol       Date:  2006-03       Impact factor: 9.302

3.  Randomized controlled trial of sirolimus for renal transplant recipients at high risk for nonmelanoma skin cancer.

Authors:  S B Campbell; R Walker; S See Tai; Q Jiang; G R Russ
Journal:  Am J Transplant       Date:  2012-03-15       Impact factor: 8.086

4.  A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention.

Authors:  Andrew C Chen; Andrew J Martin; Bonita Choy; Pablo Fernández-Peñas; Robyn A Dalziell; Catriona A McKenzie; Richard A Scolyer; Haryana M Dhillon; Janette L Vardy; Anne Kricker; Gayathri St George; Niranthari Chinniah; Gary M Halliday; Diona L Damian
Journal:  N Engl J Med       Date:  2015-10-22       Impact factor: 91.245

5.  Low-dose retinoids in the prevention of cutaneous squamous cell carcinomas in organ transplant recipients: a 16-year retrospective study.

Authors:  Catherine A Harwood; Mary Leedham-Green; Irene M Leigh; Charlotte M Proby
Journal:  Arch Dermatol       Date:  2005-04

Review 6.  A systematic review of worldwide incidence of nonmelanoma skin cancer.

Authors:  A Lomas; J Leonardi-Bee; F Bath-Hextall
Journal:  Br J Dermatol       Date:  2012-05       Impact factor: 9.302

7.  Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008--a Swedish population-based study.

Authors:  Britta Krynitz; Gustaf Edgren; Bernt Lindelöf; Eva Baecklund; Christina Brattström; Henryk Wilczek; Karin E Smedby
Journal:  Int J Cancer       Date:  2012-08-28       Impact factor: 7.396

8.  Imiquimod: potential risk of an immunostimulant.

Authors:  Elizabeth Benson
Journal:  Australas J Dermatol       Date:  2004-05       Impact factor: 2.875

9.  Belatacept and Long-Term Outcomes in Kidney Transplantation.

Authors:  Flavio Vincenti; Lionel Rostaing; Joseph Grinyo; Kim Rice; Steven Steinberg; Luis Gaite; Marie-Christine Moal; Guillermo A Mondragon-Ramirez; Jatin Kothari; Martin S Polinsky; Herwig-Ulf Meier-Kriesche; Stephane Munier; Christian P Larsen
Journal:  N Engl J Med       Date:  2016-01-28       Impact factor: 91.245

Review 10.  Azathioprine and Risk of Skin Cancer in Organ Transplant Recipients: Systematic Review and Meta-Analysis.

Authors:  Z Jiyad; C M Olsen; M T Burke; N M Isbel; A C Green
Journal:  Am J Transplant       Date:  2016-07-07       Impact factor: 8.086

View more
  5 in total

1.  Omega-3 fatty acid intake and decreased risk of skin cancer in organ transplant recipients.

Authors:  Kyoko Miura; Mandy Way; Zainab Jiyad; Louise Marquart; Elsemieke I Plasmeijer; Scott Campbell; Nicole Isbel; Jonathan Fawcett; Lisa E Ferguson; Marcia Davis; David C Whiteman; H Peter Soyer; Peter O'Rourke; Adèle C Green
Journal:  Eur J Nutr       Date:  2020-09-09       Impact factor: 5.614

2.  Organ transplantation and cutaneous squamous cell carcinoma: progress, pitfalls and priorities in immunosuppression-associated keratinocyte carcinoma.

Authors:  C A Harwood; S T Arron; C M Proby; M M Asgari; J N Bouwes Bavinck; A C Green; A E Toland
Journal:  Br J Dermatol       Date:  2017-11       Impact factor: 9.302

3.  Association between Human Leukocyte Antigen Type and Keratinocyte Carcinoma Risk in Renal Transplant Recipients.

Authors:  Yuhree Kim; David Wojciechowski; Vikram Pattanayak; Hang Lee; Maryam M Asgari
Journal:  J Invest Dermatol       Date:  2019-10-24       Impact factor: 8.551

Review 4.  Skin cancer management-updates on Merkel cell carcinoma.

Authors:  Patricia Tai; Joseph Au
Journal:  Ann Transl Med       Date:  2018-07

Review 5.  Follow-up of liver transplant recipients.

Authors:  James Neuberger
Journal:  Best Pract Res Clin Gastroenterol       Date:  2020-09-11       Impact factor: 3.043

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.